← All stories
Health, Longevity & Biohacking

OCD Ranks as Seventh Most Debilitating Illness Across All Medical Conditions

By Egleze Editorial Desk · Published July 9, 2026 · Huberman Lab · The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials
OCD Ranks as Seventh Most Debilitating Illness Across All Medical Conditions
Huberman Lab
Huberman Lab
The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials

What was said

"OCD is currently listed as number seven in terms of the most debilitating illnesses. Not just mental illnesses or disorders, but all types of illnesses, including things like asthma and cancer, etc."

Professor Andrew Huberman reveals that obsessive-compulsive disorder ranks seventh among the most debilitating of all illnesses, not just psychiatric conditions, placing it alongside conditions like asthma and cancer. With prevalence rates between 2.5-4% of the population, OCD significantly impairs work performance, relationships, and daily functioning, with sufferers spending enormous amounts of time consumed by intrusive thoughts and compulsive behaviors.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Huberman Lab
Episode
The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials
Clip time
1:16
Original source
Watch the source segment →
From this episode
Huberman Lab
Huberman Lab

The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials

July 9, 2026 · 31m · 3 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingCannabis and CBD Show No Meaningful Effect on OCD Symptoms in Laboratory Study→Health, Longevity & BiohackingCognitive Behavioral Therapy Dramatically Outperforms SSRIs for OCD Treatment Effectiveness→
More stories More from Huberman Lab